US › Healthcare

Structure Therapeutics Inc. American Depositary Shares (GPCR)

US · Healthcare · Biotechnology

$49.64+2.65%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$0
Net profit
$-76.2M
Profit YoY
-62.7%
EPS
$-0.35
EPS estimate
$-0.33

EPS came in at -0.35 against a street estimate of -0.33 — a miss of 6.1%.

Key statistics

Market cap
$3.44B
Forward P/E
0.0
P/B
2.36
Book value
$20.36
EPS (TTM)
$-2.64
52-week high
$94.90
52-week low
$15.80
50-day MA
$46.06
200-day MA
$51.95
Beta
-1.51

Analyst view

Analysts rate Structure Therapeutics Inc. American Depositary Shares a strong buy (14 buy, 0 hold, 0 sell out of 14) with an average price target of $104.83.

Shareholding

Insiders
2.66%
Institutions
96.12%

Largest institutional holders

FundStake
FMR Inc11.82%
Wellington Management Company LLP10.22%
venBio Select Advisor LLC9.22%
HHG PLC7.53%
Deep Track Capital, LP6.02%
Bvf Inc4.87%
Morgan Stanley - Brokerage Accounts3.24%
T. Rowe Price Associates, Inc.2.82%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Structure Therapeutics Inc. American Depositary Shares — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.